BR9707394A - Derivados de ácido 4-(benzo-1,3-dioxolil) pirrolidino-3-carboxílico como antagonistas endotelina - Google Patents

Derivados de ácido 4-(benzo-1,3-dioxolil) pirrolidino-3-carboxílico como antagonistas endotelina

Info

Publication number
BR9707394A
BR9707394A BR9707394A BR9707394A BR9707394A BR 9707394 A BR9707394 A BR 9707394A BR 9707394 A BR9707394 A BR 9707394A BR 9707394 A BR9707394 A BR 9707394A BR 9707394 A BR9707394 A BR 9707394A
Authority
BR
Brazil
Prior art keywords
dioxolyl
pyrrolidine
benzo
derivatives
carboxylic acid
Prior art date
Application number
BR9707394A
Other languages
English (en)
Inventor
Andrew S Tasker
Martin Winn
Thomas W Von Geldern
Bryan K Sorensen
Hwan-Soo Jae
Steven A Boyd
Kenneth J Henry
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BR9707394A publication Critical patent/BR9707394A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9707394A 1996-02-13 1997-02-10 Derivados de ácido 4-(benzo-1,3-dioxolil) pirrolidino-3-carboxílico como antagonistas endotelina BR9707394A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60072496A 1996-02-13 1996-02-13
US79450597A 1997-02-04 1997-02-04
PCT/US1997/002128 WO1997030046A1 (en) 1996-02-13 1997-02-10 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists

Publications (1)

Publication Number Publication Date
BR9707394A true BR9707394A (pt) 1999-04-06

Family

ID=27083691

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9707394A BR9707394A (pt) 1996-02-13 1997-02-10 Derivados de ácido 4-(benzo-1,3-dioxolil) pirrolidino-3-carboxílico como antagonistas endotelina

Country Status (18)

Country Link
EP (1) EP0888340B1 (pt)
JP (1) JP2000504727A (pt)
CN (1) CN1079397C (pt)
AR (1) AR005801A1 (pt)
AT (1) ATE220673T1 (pt)
AU (1) AU714597B2 (pt)
BR (1) BR9707394A (pt)
CA (1) CA2245684A1 (pt)
CZ (1) CZ253698A3 (pt)
DE (1) DE69714024T2 (pt)
DK (1) DK0888340T3 (pt)
ES (1) ES2182029T3 (pt)
HU (1) HUP9902316A3 (pt)
IL (1) IL125453A0 (pt)
NZ (2) NZ331124A (pt)
PT (1) PT888340E (pt)
WO (1) WO1997030046A1 (pt)
ZA (1) ZA971184B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208517B1 (en) 1994-08-19 2007-04-24 Abbott Labortories Endothelin antagonists
US6162927A (en) 1994-08-19 2000-12-19 Abbott Laboratories Endothelin antagonists
US6124341A (en) * 1996-02-13 2000-09-26 Abbott Laboratories Endothelin antagonists
AU7826398A (en) * 1997-06-17 1999-01-04 Abbott Laboratories Pyrrolidine carboxylic acid derivatives as endothelin antagonists
CN1301264A (zh) * 1997-08-04 2001-06-27 艾博特公司 内皮素拮抗剂
CN100406439C (zh) * 2000-07-19 2008-07-30 霍夫曼-拉罗奇有限公司 作为金属蛋白酶抑制剂的吡咯烷衍生物
WO2002017912A1 (en) * 2000-08-31 2002-03-07 Abbott Laboratories Endothelin antagonists
RU2259825C9 (ru) 2001-06-18 2006-04-10 БиоДием Лимитед Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ287406B6 (cs) * 1991-11-05 2000-11-15 Smithkline Beecham Corporation Indanové a indenové deriváty, způsob jejich výroby a farmaceutické prostředky s jejich obsahem
JPH07509465A (ja) * 1992-07-17 1995-10-19 スミスクライン・ビーチャム・コーポレイション エンドセリン受容体アンタゴニスト
DE69527072T2 (de) * 1994-08-19 2003-02-13 Abbott Lab Endothelin antagoniste

Also Published As

Publication number Publication date
JP2000504727A (ja) 2000-04-18
NZ331124A (en) 2000-05-26
AU2267897A (en) 1997-09-02
DE69714024T2 (de) 2003-03-20
CZ253698A3 (cs) 1999-03-17
EP0888340B1 (en) 2002-07-17
WO1997030046A1 (en) 1997-08-21
CN1079397C (zh) 2002-02-20
HUP9902316A3 (en) 2001-12-28
HUP9902316A2 (hu) 1999-11-29
ATE220673T1 (de) 2002-08-15
CN1215401A (zh) 1999-04-28
DE69714024D1 (de) 2002-08-22
CA2245684A1 (en) 1997-08-21
ES2182029T3 (es) 2003-03-01
NZ503383A (en) 2002-02-01
PT888340E (pt) 2002-12-31
IL125453A0 (en) 1999-03-12
EP0888340A1 (en) 1999-01-07
ZA971184B (en) 1997-08-27
AR005801A1 (es) 1999-07-14
AU714597B2 (en) 2000-01-06
DK0888340T3 (da) 2002-11-04

Similar Documents

Publication Publication Date Title
PT1109558E (pt) Formulacoes de ranolazina de libertacao controlada
ATE228117T1 (de) Kristalline form von 4-(5-methyl-3-phenylisoxazol-4-yl)benzolsulfona id
BR0000327B1 (pt) cabeÇa de poÇo.
ATE323697T1 (de) Neue benzo-1,3-dioxolyl-und benzofuranyl substituierte pyrrolidinederivate als endothelin antagonisten
CU23047A3 (es) Derivados de aminoacidos halogenados utiles como inhibidores de la oxido nitrico-sintasa.
DE60008524D1 (de) Furanonderivate als inhibitoren von cathepsin s
DE59910836D1 (de) Dermal applizierbare wasserhaltige formulierungen von parasitiziden
PT1023268E (pt) Isoquinolinas como inibidores de uroquinase
PT1216250E (pt) Derivados propilicos substituidos de tienoisoxazolil- e tienilpirrazolil-fenoxi uteis como antagonistas d4
DE60038118D1 (de) Formulierungen von wachstumshormonen
BR9707394A (pt) Derivados de ácido 4-(benzo-1,3-dioxolil) pirrolidino-3-carboxílico como antagonistas endotelina
PT964863E (pt) Oxazolidinonas como antagonistas de 5-ht2a
PT1214302E (pt) 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas substituidas e sua utilizacao como inibidores de lipase
DK1702623T3 (da) Anvendelse af interferon-gamma til behandling af hjertehypertrofi
ATE222456T1 (de) Stabilisierung von isothiazolonen
DE50009938D1 (de) Verwendung von nanoskaligen wachsen
DE60026931D1 (de) Ausrichtung von Ausdrucken
PT1173437E (pt) Derivado de tiazolidinodiona e sua utilizacao como antidiabetico
DE60011935D1 (de) Verwendung von diflufenzopyr zur frühen terminierung von pflanzen
DE60042386D1 (de) Verbesserte operationsverstärkerausgangsstufe
DE50006852D1 (de) Verwendung von nanoskaligen deodorantien
NO996244D0 (no) Pyrrolidinkarboksylsyrederivater som endotelinantagonister
DE60012953D1 (de) 3-amino-2-phenylpiperidinderivate als substanz p antagonisten
PT1121349E (pt) Tiadiazolsulfonamidas substituidas como inibidores de interleucina-1-beta
ATE525362T1 (de) 2-(3-(4-(2-t-butyl-6-trifluormethylpyrimidin-4-

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements